Lixte Biotechnology Holdings Inc. (LIXT) Stock’s Detailed Analysis

view original post

Lixte Biotechnology Holdings Inc. (NASDAQ:LIXT) has a beta value of -1.65 and has seen 1.12 million shares traded in the last trading session. The company, currently valued at $30.50M, closed the last trade at $2.14 per share which meant it lost -$0.08 on the day or -3.60% during that session. The LIXT stock price is -235.98% off its 52-week high price of $7.19 and 48.13% above the 52-week low of $1.11. If we look at the company’s 10-day average daily trading volume, we find that it stood at 13.03 million shares traded. The 3-month trading volume is 2.06 million shares.

Sporting -3.60% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 01/07/22 when the LIXT stock price touched $2.14 or saw a rise of 30.97%. Year-to-date, Lixte Biotechnology Holdings Inc. shares have moved 79.83%, while the 5-day performance has seen it change 79.83%. Over the past 30 days, the shares of Lixte Biotechnology Holdings Inc. (NASDAQ:LIXT) have changed 40.79%. Short interest in the company has seen 41720.0 shares shorted with days to cover at 0.62.

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

Lixte Biotechnology Holdings Inc. (LIXT) estimates and forecasts

The company’s shares have lost -34.15% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 4.60% over the past 5 years.

LIXT Dividends

Lixte Biotechnology Holdings Inc. is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Lixte Biotechnology Holdings Inc. (NASDAQ:LIXT)’s Major holders

Insiders own 67.13% of the company shares, while shares held by institutions stand at 8.82% with a share float percentage of 26.83%. Investors are also buoyed by the number of investors in a company, with Lixte Biotechnology Holdings Inc. having a total of 11 institutions that hold shares in the company. The top two institutional holders are Almanack Investment Partners, LLC. with over 0.81 million shares worth more than $1.68 million. As of Sep 29, 2021, Almanack Investment Partners, LLC. held 1.20% of shares outstanding.

The other major institutional holder is Santa Monica Partners LP, with the holding of over 0.17 million shares as of Sep 29, 2021. The firm’s total holdings are worth over $0.35 million and represent 0.25% of shares outstanding.

>> 7 Top Picks for the Post-Pandemic Economy <<

Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Vanguard Total Stock Market Index Fund. As of Sep 29, 2021, the former fund manager holds about 0.07% shares in the company for having 48388.0 shares of worth $0.1 million while later fund manager owns 25995.0 shares of worth $54069.0 as of Sep 29, 2021, which makes it owner of about 0.04% of company’s outstanding stock.